Literature DB >> 23754141

Extended lymphadenectomy in colon cancer is crucial.

Hermann Kessler1, Werner Hohenberger.   

Abstract

No one doubts that lymph node dissection in colon cancer is necessary, it is just the extent of that dissection that is still under debate. As the individual steps of an oncologic operation cannot be separated from each other, analysis of the significance of lymph node dissection alone is difficult. It has been proven that the T category is directly related to the number and central spread of lymph node metastases. Micrometastases and isolated tumor cells may be detected in lymph nodes by using special staining techniques; their presence may worsen prognosis significantly and approximate it to UICC stage III. The numbers of dissected lymph nodes and the ratio of involved versus dissected lymph nodes have been used as markers for quality of surgery and histopathological evaluation. Recent results underscore the importance of technique and extent of dissection. Dissection must be performed along the embryologic planes of the mesocolon and leave them intact. A high vascular tie with preservation of the central hypogastric nerves must be applied in order to achieve the best oncologic results while preserving quality of life. Extended lymphadenectomy is oncologically relevant only when it is combined with removal of the primary tumor with adequate longitudinal clearance, an intact complete mesocolon, and high vascular tie. It is part of a concept in which the tumor-bearing specimen is harvested as an enveloped package to minimize the risk of tumor cell spillage and local recurrence.

Entities:  

Mesh:

Year:  2013        PMID: 23754141     DOI: 10.1007/s00268-013-2130-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  79 in total

1.  Current concepts in cancer. Cancer of the GI tract: colon, rectum, anus. The no-touch isolation technique of resection.

Authors:  R B Turnbull
Journal:  JAMA       Date:  1975-03-17       Impact factor: 56.272

2.  How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.

Authors:  Kazuhiko Yoshimatsu; Keiichiro Ishibashi; Arihiro Umehara; Hajime Yokomizo; Kiyohito Yoshida; Takashi Fujimoto; Kiyo Watanabe; Kenji Ogawa
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

3.  Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial.

Authors:  L Påhlman; B Glimelius
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

4.  Optimal margins and lymphadenectomy in colonic cancer surgery.

Authors:  Y Hashiguchi; K Hase; H Ueno; H Mochizuki; E Shinto; J Yamamoto
Journal:  Br J Surg       Date:  2011-05-10       Impact factor: 6.939

5.  The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.

Authors:  Robert Rosenberg; Jutta Engel; Christiane Bruns; Wolfgang Heitland; Nikolaus Hermes; Karl-Walter Jauch; Reinhard Kopp; Eberhard Pütterich; Reinhard Ruppert; Tibor Schuster; Helmut Friess; Dieter Hölzel
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

6.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

7.  Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer.

Authors:  Ole H Sjo; Marianne A Merok; Aud Svindland; Arild Nesbakken
Journal:  Dis Colon Rectum       Date:  2012-03       Impact factor: 4.585

8.  Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.

Authors:  Ugur Berberoglu
Journal:  Hepatogastroenterology       Date:  2004 Nov-Dec

9.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

Review 10.  Preparing the "soil": the premetastatic niche.

Authors:  Rosandra N Kaplan; Shahin Rafii; David Lyden
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

View more
  12 in total

1.  Surgical and oncological outcomes after complete mesocolic excision in right-sided colon cancer compared with conventional surgery: a retrospective, single-institution study.

Authors:  Tommaso Zurleni; Alberto Cassiano; Elson Gjoni; Andrea Ballabio; Giovanni Serio; Luca Marzoli; Francesco Zurleni
Journal:  Int J Colorectal Dis       Date:  2017-10-16       Impact factor: 2.571

2.  International survey among surgeons on the perioperative management of rectal cancer.

Authors:  Zaid Al-Difaie; Nariaki Okamoto; Max H M C Scheepers; Didier Mutter; Laurents P S Stassen; Nicole D Bouvy; Jacques Marescaux; Bernard Dallemagne; Michele Diana; Mahdi Al-Taher
Journal:  Surg Endosc       Date:  2022-10-18       Impact factor: 3.453

3.  Extended Lymphadenectomy for Proximal Transverse Colon Cancer: Is There a Place for Standardization?

Authors:  Răzvan Cătălin Popescu; Florin Botea; Eugen Dumitru; Laura Mazilu; Luminița Gențiana Micu; Cristina Tocia; Andrei Dumitru; Adina Croitoru; Nicoleta Leopa
Journal:  Medicina (Kaunas)       Date:  2022-04-26       Impact factor: 2.948

4.  Initial experience of laparoscopic right hemicolectomy with complete mesocolic excision in Singapore: a case series.

Authors:  Ming Li Ho; Cheryl Chong; Shen Ann Yeo; Chee Yung Ng
Journal:  Singapore Med J       Date:  2019-01-15       Impact factor: 1.858

Review 5.  Complete mesocolic excision for colon cancer: is it worth it?

Authors:  Frederick H Koh; Ker-Kan Tan
Journal:  J Gastrointest Oncol       Date:  2019-12

Review 6.  Complete mesocolic excision and extended (D3) lymphadenectomy for colonic cancer: is it worth that extra effort? A review of the literature.

Authors:  Andrew Emmanuel; Amyn Haji
Journal:  Int J Colorectal Dis       Date:  2016-01-30       Impact factor: 2.571

7.  Protocol for a multicentre randomized clinical trial comparing oncological outcomes of D2 versus D3 lymph node dissection in colonic cancer (COLD trial).

Authors:  A Karachun; A Petrov; L Panaiotti; Y Voschinin; T Ovchinnikova
Journal:  BJS Open       Date:  2019-03-14

8.  Short- and long-term outcomes of rectal cancer patients with high or improved low ligation of the inferior mesenteric artery.

Authors:  Chenghai Zhang; Lei Chen; Ming Cui; Jiadi Xing; Hong Yang; Zhendan Yao; Nan Zhang; Fei Tan; Maoxing Liu; Kai Xu; Xiangqian Su
Journal:  Sci Rep       Date:  2020-09-18       Impact factor: 4.379

9.  Randomized clinical trial of high versus low inferior mesenteric artery ligation during anterior resection for rectal cancer.

Authors:  S Fujii; A Ishibe; M Ota; K Watanabe; J Watanabe; C Kunisaki; I Endo
Journal:  BJS Open       Date:  2018-06-08

10.  Re-interpreting mesenteric vascular anatomy on 3D virtual and/or physical models: positioning the middle colic artery bifurcation and its relevance to surgeons operating colon cancer.

Authors:  Bjarte T Andersen; Bojan V Stimec; Bjørn Edwin; Airazat M Kazaryan; Przemyslaw J Maziarz; Dejan Ignjatovic
Journal:  Surg Endosc       Date:  2021-01-25       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.